Brady Kelly sold MCRB
May 18, 2026 · Form 4 insider transaction
Brady Kelly sold 59 shares of Seres Therapeutics, Inc. at $7.53 per share, a transaction worth $444.27. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
59
Price
$7.53
Total value
$444.27
InsiderBrady Kelly
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 18, 2026
Filing dateMay 19, 2026
Shares owned after8,562
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold to cover taxes in connection with the vesting of the restricted stock units.